Cardiovascular

The proposed merger comes at a time when many companies have backed away from deals because of the COVID-19 pandemic.

Abiomed said it was granted Emergency Use Authorization for the Impella RP to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism. The Danvers, MA-based company initially received...

The Seattle, WA-based company also won CE mark for a 14-day version of the Carnation Ambulatory Monitor.

The Irvine, CA-based company said its Pascal System has not yet been approved in the U.S.

The Danvers, MA-based company also posted results that beat Wall Street expectations.

Portland, OR-based VisCardia is developing VisOne, an implantable system that delivers synchronized diaphragmatic stimulation (SDS) therapy for improving cardiac function.

Rehovot, Israel-based Pi-Cardia has raised $27 million to help establish the efficacy and long-term safety of its Leaflex Catheter.

The Minneapolis, MN-based company’s VenTouch is a minimally invasive option and combination therapy that simultaneously treats the distorted valve, the dilated ventricle and the displaced papillary muscles in patients suffering from Type IIIb...

Impulse Dynamics closed out 2019 by raising $80.3M in a series D round. Now the MT. Laurel, N.J.-based company is moving quickly in 2020 by enrolling the first patient in its post-approval study of the Optimizer system, which delivers Cardiac...